Ethical issues and public communication in the development of cell-based treatments for COVID-19: Lessons from the pandemic
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Ethical issues and public communication in the development of cell-based treatments for COVID-19: Lessons from the pandemic
Authors
Keywords
COVID-19, unproven stem cell interventions, FDA, FTC, therapeutic hype, public communication
Journal
Stem Cell Reports
Volume 16, Issue 11, Pages 2567-2576
Publisher
Elsevier BV
Online
2021-10-16
DOI
10.1016/j.stemcr.2021.09.005
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Umbilical cord mesenchymal stem cells for COVID ‐19 acute respiratory distress syndrome: A double‐blind, phase 1/2a, randomized controlled trial
- (2021) Giacomo Lanzoni et al. Stem Cells Translational Medicine
- The US Regulatory System and COVID-19 Vaccines
- (2021) Joshua M. Sharfstein et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- SARS-CoV-2 Vaccines
- (2021) C. Buddy Creech et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The evolving role of preprints in the dissemination of COVID-19 research and their impact on the science communication landscape
- (2021) Nicholas Fraser et al. PLOS BIOLOGY
- Current evidence for COVID-19 therapies: a systematic literature review
- (2021) Tobias Welte et al. European Respiratory Review
- Long COVID has exposed medicine's blind-spot
- (2021) Matthew J Burke et al. LANCET INFECTIOUS DISEASES
- Anticipated impact of stem cell and other cellular medicine clinical trials for COVID-19
- (2021) Mina Kim et al. Regenerative Medicine
- Updates on clinical trials evaluating the regenerative potential of allogenic mesenchymal stem cells in COVID-19
- (2021) Dhavan Sharma et al. npj Regenerative Medicine
- A Novel Coronavirus from Patients with Pneumonia in China, 2019
- (2020) Na Zhu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Preying on Public Fears and Anxieties in a Pandemic: Businesses Selling Unproven and Unlicensed “Stem Cell Treatments” for COVID-19
- (2020) Leigh Turner Cell Stem Cell
- Current Status of Cell-Based Therapies for Respiratory Virus Infections: Applicability to COVID-19
- (2020) Maroun Khoury et al. EUROPEAN RESPIRATORY JOURNAL
- Against pandemic research exceptionalism
- (2020) Alex John London et al. SCIENCE
- From deficit to dialogue in science communication
- (2020) Cathelijne M Reincke et al. EMBO REPORTS
- Communicating Science in the Time of a Pandemic
- (2020) Richard Saitz et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A Scoping Review of Registered Clinical Trials of Cellular Therapy for COVID-19 and a Framework for Accelerated Synthesis of Trial Evidence—FAST Evidence
- (2020) Gary Liao et al. TRANSFUSION MEDICINE REVIEWS
- The coronavirus pandemic: a pitfall or a fast-track for validating cell therapy products?
- (2020) maroun khoury et al. STEM CELLS AND DEVELOPMENT
- Medical societies, patient education initiatives, public debate and marketing of unproven stem cell interventions
- (2018) Daniel J. Weiss et al. CYTOTHERAPY
- Concise Review: A Comprehensive Analysis of Reported Adverse Events in Patients Receiving Unproven Stem Cell-Based Interventions
- (2018) Gerhard Bauer et al. Stem Cells Translational Medicine
- Marketing of unproven stem cell–based interventions: A call to action
- (2017) Douglas Sipp et al. Science Translational Medicine
- Confronting stem cell hype
- (2016) T. Caulfield et al. SCIENCE
- Responsible Use of Language in Scientific Writing and Science Communication
- (2014) Christoph Kueffer et al. BIOSCIENCE
- Systematic Review of the Empirical Evidence of Study Publication Bias and Outcome Reporting Bias — An Updated Review
- (2013) Kerry Dwan et al. PLoS One
- COMPASS: Navigating the Rules of Scientific Engagement
- (2013) Brooke Smith et al. PLOS BIOLOGY
- Science and the Sources of Hype
- (2012) T. Caulfield et al. Public Health Genomics
- Fixing the communications failure
- (2010) Dan Kahan NATURE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now